The Foundation's impact
An Interview with Boehringer Ingelheim's Maria Lucia Tereno and Dr Ina Witte
This interview with Boehringer Ingelheim sheds light on how they are using the Access to Medicine Foundation's research and insights, and reflect on how the Foundation is driving change across the global health ecosystem.
Our Engagement
An interview with Michael Oberreiter, Roche, and Pritha Paul, Biocon Biologics Limited
This interview sheds light on how the Foundation has impacted companies, from showcasing best practices to providing insights that can be used to expand access.
Stakeholder engagements
Watch the videos to learn more about the impact of our work so farAn interview with Esteban Burrone, Head of Policy, Strategy and Market Access at MPP
An interview with Dr Joseph Saba, Chief Executive Officer at Axios International
An interview with Frank Wagemans, Senior Engagement Specialist at Achmea IM
An interview with Dr Zainab Shinkafi Bagudu, CEO at Medicaid Cancer Foundation
An interview with Dr Ebere Okereke, CEO at Africa Public Health Foundation
An interview with Mariângela Simão, Director-President of the Instituto Todos pela Saúde
Creating impact: Access to Medicine Foundation
Our global health partners share their thoughts on the Foundation’s changemaking activities and reflect on the impact the Foundation is having on expanding access to medicine.
When I talk to executives from pharmaceutical companies they tell me that they want to do more for neglected diseases, but they at least need to get credit for it. The Access to Medicine Index does exactly that.
all endorsementsBill Gates
Co-chair and Trustee, Bill & Melinda Gates Foundation
An interview with Dr Linda-Gail Bekker, CEO at Desmond Tutu Health Foundation
Dr Linda-Gail Bekker, Chief Executive Officer of the Desmond Tutu Health Foundation and Chair of the Access to Medicine Foundation’s Supervisory Board, shares her thoughts on what pharmaceutical companies can do to scale up access to medicine for people living in low- and middle-income countries.
Stakeholder engagements
Watch the fireside chatsFireside chat: Scaling up access to insulin for people living in low- and middle-income countries
Fireside chat: Scaling up access to glucose self-monitoring devices along the diabetes continuum of care
Fireside chat: Promoting holistic access to essential diabetes care products throughout the continuum of care
Africa has been overlooked when it comes to research and development of life-saving medical commodities, including COVID-19 vaccines. Free market demand and supply principles will not work on their own without an equitable access dimension. The Access to Medicine Foundation is important for accountability - tracking how and where healthcare companies live up to their commitments; as well as encouraging them to do better – in bridging gaps in equitable access to health products and achieving universal health coverage.
Dr Githinji Gitahi
Group CEO, Amref Health Africa
An interview with James Reid, Program Officer, Type 1 Diabetes at The Helmsley Charitable Trust
He talks about how The Helmsley Charitable Trust is using the Foundation’s insights and how the two organisations are working together towards a common goal of increasing access to healthcare.
Diabetes advocate Bridget McNulty shares why "collaboration is essential" to improving access to care in South Africa
Global oxygen suppliers commit to closing oxygen gaps in low- and middle-income countries
AMR Register: A global AMR surveillance data sharing platform
An interview with Dr Luis Pizzaro, Executive Director at DNDi
He talks about how DNDi is using the Foundation’s insights to drive its mission and how the two organisations are collaborating to achieve a common goal of universal health access.
Explore our research sectors
Margo Warren
Director of Government Engagement & Policy
mwarren@Accesstomedicinefoundation.org
Get in touch